VELOSEF '250' (CEPHRADINE) — FDA Approval ANDA061763 (APOTHECON)
VELOSEF '250' (CEPHRADINE) — FDA Approval ANDA061763 (APOTHECON) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: VELOSEF '250'; Active ingredients: CEPHRADINE; Application number: ANDA061763.
| Brand name | VELOSEF '250' |
|---|---|
| Active ingredients | CEPHRADINE |
| Application number | ANDA061763 |
| Sponsor | APOTHECON |
| Dosage form | FOR SUSPENSION |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19740819 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →